Scholars Central

Conference abstract

Need for cost effective substantiation of efficacy of nutritional health claims through bioavailability data for wide penetration of dietary supplements in the national health care systems

Authors: D. P. Attrey

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Dietary supplements (DS) are multi-billion dollar business. Their safety and efficacy is validated to ensure true label claims. No Food Business Operator (FBO) is supposed to guarantee efficacy with inadequate scientific justification. Burden of proof of scientific justification is on the FBO instead of regulator. DS differ from drugs (which are intended to diagnose, cure, mitigate, treat, or prevent a disease); both intending to affect body structure and function. Drugs have to be pre approved by FDA (after clinical validation of safety and efficacy); DS do not require prior FDA approval or pre-market testing. Regulators need substantiated evidence of safety for which they are responsible to the public. But for making the health claims true and not misleading, documentation for efficacy has also to be generated by concerned FBO through demonstrated substantiation. Bioavailability (BA) of the product is a major tool for substantiation of efficacy. DS fall in grey area between food and drugs. Their efficacy issue, based on BA substantiation, cannot be as rigorous as for drugs and needs to be revisited for economical production of DS. It is neither understood properly by researchers nor implemented properly by industry to satisfy the regulatory requirements. Discussion on removal of ?prevention? clause from the disease claims and incorporating it in structure and function or Disease Risk Reduction (DRR) Claims, without affecting the public interest, also appears to be the need of the day. This is likely to benefit healthcare systems as well as industry, immensely

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “D. P. Attrey”